Community/Retail

PillPack has brought multidose drug dispensing systems to the public forefront. When will other companies catch on?

Eli Lilly and Company has committed another 780,000 vials of insulin to the International Diabetes Federation's Life for a Child program.

Routine medical tests are still frequently performed before low-risk surgeries, despite clinical guidelines recommending against such preoperative screening.

If the health care industry adopted objective grading for performance, there would be greater incentive for facilities to provide the highest quality of care.

Teva has introduced norethindrone acetate-ethinyl estradiol/ferrous fumarate (Junel Fe 24) tablets, a generic alternative to Amneal's Lomedia 24 Fe oral contraceptive, to the US market.

The Missouri State Board of Pharmacy has placed a state legislator's pharmacy license on probation for 3 years for dispensing pills improperly.

Fred Eckel, RPh, MS, Editor-in-Chief of Pharmacy Times, discusses his thoughts on recent changes to the pharmacy industry.

Americans are increasingly engaging in heavy drinking and binge drinking.

Lithium remains a treatment of choice for bipolar disorder, as it is very effective in stabilizing mood and reducing suicide risk. However, its use is associated with adverse renal and thyroid effects.

Pharmacy-based transition of care (TOC) interventions that include post-discharge medication therapy management (MTM) services are strongly correlated with reduced hospital readmissions.

The FDA has granted priority review to Merck's pembrolizumab (Keytruda) for the treatment of advanced non-small cell lung cancer (NSCLC).

MinuteClinic announced that it has become an in-network provider with Molina Healthcare of Ohio, a health care insurance plan serving 340,000 members.

CVS/pharmacy has launched a new shopping experience in Miami -- CVS/pharmacy y mas " to provide enhanced, personalized service to the Hispanic community.

In response to a proposed Senate amendment to the National Defense Authorization Act, the United States Pharmacopeial Convention issued a statement.

It's no secret that pharmacy technicians are becoming a more integral part of the pharmacy team.

Pharmacists can play an important role in educating patients on the dangers of abusing Flakka.

The American Medical Association and American Hospital Association today released a new set of guiding principles for bringing clinical skills and business insights together.

Recent research findings may help health care professionals participating in a new Affordable Care Act payment model identify patients at greatest risk for cardiovascular disease (CVD).

Rolee Pathak Das, PharmD, BCPS, clinical associate professor at Rutgers University Ernest Mario School of Pharmacy, talks about how the role of the pharmacist has changed.

Sunbathers lathering up with suntan lotion have a pharmacist to thank for the original Coppertone formula.

Even though school is out and kids no longer have their routine physical education classes, parents can keep them active this summer with the newly launched Hy-Vee KidsFit website.

A West Virginia high court's decision to allow drug abusers to sue pharmacists could have a far-reaching influence on controlled substance dispensing.

Teva recently launched risedronate sodium tablets, the generic version of Actavis's Actonel bisphosphonate, in 3 dosage strengths.

So far, the market has absorbed the increasing number of pharmacy graduates, but some wonder when the pharmacy bubble will burst.

Almost all opioid addicts on methadone maintenance treatment (MMT) are cut off from the medicine when incarcerated, but this interruption reduces their inclination to seek addiction treatment.

Astellas Pharma Inc. and Anokion today announced an agreement to collaborate in the fields of type 1 diabetes and celiac disease.

Actavis is proud to participate in today's White House Forum on Antibiotic Stewardship.

"The American Medical Association commends the U.S. House of Representatives' Ways and Means Committee for the repeal of the Independent Payment Advisory Board provision of the Affordable Care Act.

Amgen today announced a collaboration with Roche on a Phase 1b study to evaluate the safety and efficacy of talimogene laherparepvec, Amgen's investigational oncolytic immunotherapy.